GlassScriptPhysician profile
Jessica Baldetti
NPI 1134508864
$5,622.69
in general payments reported to CMS, 2019-2025
41 companies · $687 in 2025
The $687 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $636 · 2021: $1,183 · 2022: $949 · 2023: $995 · 2024: $837 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,517.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,322.26 | 2019-2025 | Liletta, Orilissa, Lo Loestrin Fe |
| Evofem Biosciences, INC. | $681.94 | 2020-2025 | Phexxi, Solosec, Phexx |
| Astellas Pharma US INC | $258.08 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $249.57 | 2021-2025 | |
| Therapeuticsmd, INC. | $208.95 | 2019-2022 | |
| Exeltis, USA INC. | $166.54 | 2021-2025 | Slynd |
| Hologic Sales and Service, LLC | $165.90 | 2022-2025 | Myosure Tissue Removal Device, Novasure, Omni Hysteroscope |
| Pfizer INC. | $158.48 | 2020-2025 | |
| Sage Therapeutics, LLC | $153.98 | 2021-2025 | Zurzuvae |
| Organon LLC | $150.07 | 2021-2025 | Nexplanon |
| Agile Therapeutics, INC. | $143.93 | 2021-2023 | Twirla |
| Novo Nordisk INC | $140.49 | 2023-2025 | Wegovy |
| Exact Sciences Corporation | $135.93 | 2023-2024 | Cologuard Collection Kit |
| Mission Pharmacal Company | $131.24 | 2020-2021 | |
| Myovant Sciences INC. | $128.61 | 2021-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $121.84 | 2020 | |
| Sumitomo Pharma America, INC. | $118.12 | 2023-2025 | Myfembree, Gemtesa |
| Shield Therapeutics INC | $94.50 | 2023-2024 | Accrufer |
| Merck Sharp & Dohme LLC | $93.26 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.95 | 2020-2023 | |
| Ethicon US, LLC | $84.77 | 2022 | |
| Lilly USA, LLC | $80.34 | 2022-2025 | Zepbound, Mounjaro |
| Millicent US INC | $79.28 | 2024-2025 | Intrarosa |
| Optumhealth Care Solutions, LLC | $76.68 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Lupin INC. | $73.34 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $65.26 | 2021-2022 | |
| Amgen INC. | $60.10 | 2021-2024 | Prolia, Evenity |
| Daiichi Sankyo INC. | $47.58 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $42.31 | 2022 | |
| Avion Pharmaceuticals | $40.63 | 2023 | Balcoltra |
| Lsi Solutions INC | $39.26 | 2024 | Fornisee |
| Smith+Nephew, INC. | $36.95 | 2023 | Pico 7, Renasys Go V2 Home |
| Minerva Surgical, INC | $31.30 | 2023 | |
| Coopersurgical, INC. | $24.93 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $22.89 | 2021 | |
| Meditrina | $22.06 | 2021 | |
| Allergan, INC. | $20.95 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $19.24 | 2021 | |
| Medtronic, INC. | $16.60 | 2023 | V-Loc 180 |
| Davol INC. | $15.72 | 2023 | Arista Ah Flexitip |
| Cumberland Pharmaceuticals, INC. | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Baldetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.